News

According to property advisor Knight Frank, venture capital (VC) funding into the UK life sciences sector reached £1.1 ...
Enara Bio, a privately-held UK biopharma developing bispecific T-cell engagers, has announced the appointment of Stacey Davis ...
The US Food and Drug Administration (FDA) has approved Imaavy (nipocalimab-aahu), a human FcRn-blocking monoclonal antibody, ...